Avoro Capital Advisors
$10.2B 13F equity value
37 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 2,630,000 | $1.6B | 15.4% |
| ASND | ASCENDIS PHARMA | 5,062,500 | $1.2B | 11.4% |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,818,181 | $952M | 9.4% |
| KRYS | KRYSTAL BIOTECH INC | 2,888,888 | $746M | 7.4% |
| ARGX | ARGENX SE | 1,000,000 | $730M | 7.2% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 10,699,999 | $671M | 6.6% |
| KYMR | KYMERA THERAPEUTICS INC | 7,474,747 | $623M | 6.1% |
| APLS | APELLIS PHARMACEUTICALS INC | 12,222,222 | $492M | 4.8% |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 11,430,455 | $454M | 4.5% |
| CELC | CELCUITY INC | 3,375,000 | $385M | 3.8% |
Track Avoro Capital Advisors's 13F portfolio: $10.2B in reported holdings, 37 positions. Top holdings and quarterly changes on SentiSense.